Cancer-Associated Mutations Reveal a Novel Role for EpCAM as an Inhibitor of Cathepsin-L and Tumor Cell Invasion
Narendra V. Sankpal(Washington University in St. Louis), William E. Gillanders(Washington University in St. Louis)
Cited by 0
Related Papers
Activator protein 1 (AP-1) contributes to EpCAM-dependent breast cancer invasion
|Breast Cancer Research|2011|53
Cancer-associated mutations reveal a novel role for EpCAM as an inhibitor of cathepsin-L and tumor cell invasion
|BMC Cancer|2021|14